IL6 and chronic obstructive pulmonary disease: The systemic spillover of pro-inflammatory mediators (IL-6, IL-8, tumor necrosis factor α) from the lungs, prompting platelet activation, endothelial inflammation and atherosclerosis has been considered the major pathogenic mechanism of exalted cardiovascular risk after acute exacerbated COPD [42,43,44].